A total number of 6 unstable decongested chronic HF patients due to ischemic, idiopathic dilated, and peripartum cardiomyopathy consisting of four males and two females with median age of 51 years were enrolled in the study and received daily 8 IU of GH subcutaneously for median of 26 days. The gene discussed is GH1; the disease is peripartum cardiomyopathy.